Strategic Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $439K | Sell |
18,216
-1,935
| -10% | -$50.6K | 0.1% | 119 |
|
|
2026
Q1 | $566K | Buy |
20,151
+2,829
| +16% | +$75.3K | 0.09% | 127 |
|
|
2025
Q4 | $431K | Sell |
17,322
-1,601
| -8% | -$40.4K | 0.07% | 142 |
|
|
2025
Q3 | $482K | Hold |
18,923
| – | – | 0.08% | 136 |
|
|
2025
Q2 | $459K | Sell |
18,923
-4,370
| -19% | -$102K | 0.09% | 123 |
|
|
2025
Q1 | $590K | Sell |
23,293
-10,204
| -30% | -$267K | 0.11% | 124 |
|
|
2024
Q4 | $889K | Sell |
33,497
-97,769
| -74% | -$2.65M | 0.16% | 109 |
|
|
2024
Q3 | $3.8M | Buy |
131,266
+4,473
| +4% | +$130K | 0.71% | 33 |
|
|
2024
Q2 | $3.55M | Buy |
126,793
+1,767
| +1% | +$48.6K | 0.69% | 32 |
|
|
2024
Q1 | $3.47M | Buy |
125,026
+12,809
| +11% | +$355K | 0.68% | 34 |
|
|
2023
Q4 | $3.23M | Sell |
112,217
-23,849
| -18% | -$721K | 0.61% | 35 |
|
|
2023
Q3 | $4.51M | Sell |
136,066
-7,403
| -5% | -$262K | 0.89% | 28 |
|
|
2023
Q2 | $5.26M | Sell |
143,469
-7,228
| -5% | -$281K | 1% | 27 |
|
|
2023
Q1 | $6.15M | Buy |
150,697
+4,607
| +3% | +$199K | 1.24% | 21 |
|
|
2022
Q4 | $7.49M | Sell |
146,090
-3,986
| -3% | -$191K | 1.67% | 14 |
|
|
2022
Q3 | $6.57M | Sell |
150,076
-2,454
| -2% | -$119K | 1.46% | 18 |
|
|
2022
Q2 | $8M | Sell |
152,530
-4,394
| -3% | -$224K | 1.67% | 15 |
|
|
2022
Q1 | $8.12M | Buy |
156,924
+59,812
| +62% | +$3.1M | 1.41% | 15 |
|
|
2021
Q4 | $5.73M | Buy |
97,112
+46,029
| +90% | +$2.28M | 0.82% | 36 |
|
|
2021
Q3 | $2.2M | Sell |
51,083
-978
| -2% | -$43.3K | 0.47% | 48 |
|
|
2021
Q2 | $2.04M | Buy |
52,061
+38,296
| +278% | +$1.49M | 0.53% | 41 |
|
|
2021
Q1 | $498K | Sell |
13,765
-33,913
| -71% | -$1.2M | 0.14% | 110 |
|
|
2020
Q4 | $1.77M | Sell |
47,678
-31,461
| -40% | -$1.15M | 0.51% | 44 |
|
|
2020
Q3 | $2.76M | Sell |
79,139
-2,795
| -3% | -$98K | 0.93% | 25 |
|
|
2020
Q2 | $3M | Buy |
81,934
+12,220
| +18% | +$415K | 1.12% | 19 |
|
|
2020
Q1 | $2.29M | Sell |
69,714
-5,056
| -7% | -$172K | 1% | 21 |
|
|
2019
Q4 | $2.78M | Sell |
74,770
-1,066
| -1% | -$38K | 0.97% | 22 |
|
|
2019
Q3 | $2.58M | Sell |
75,836
-2,533
| -3% | -$92.1K | 0.97% | 24 |
|
|
2019
Q2 | $3.22M | Sell |
78,369
-255
| -0.3% | -$10.1K | 1.23% | 21 |
|
|
2019
Q1 | $3.17M | Sell |
78,624
-2,130
| -3% | -$85.3K | 1.22% | 20 |
|
|
2018
Q4 | $3.34M | Sell |
80,754
-1,915
| -2% | -$79.5K | 1.46% | 20 |
|
|
2018
Q3 | $3.46M | Sell |
82,669
-101
| -0.1% | -$3.89K | 1.27% | 22 |
|
|
2018
Q2 | $2.85M | Buy |
82,770
+110
| +0.1% | +$3.76K | 1.14% | 27 |
|
|
2018
Q1 | $2.78M | Sell |
82,660
-1,179
| -1% | -$40.5K | 1.15% | 27 |
|
|
2017
Q4 | $2.88M | Sell |
83,839
-1,283
| -2% | -$43.7K | 1.18% | 25 |
|
|
2017
Q3 | $2.88M | Buy |
85,122
+1,139
| +1% | +$36.6K | 1.25% | 25 |
|
|
2017
Q2 | $2.68M | Buy |
83,983
+26,269
| +46% | +$828K | 1.22% | 25 |
|
|
2017
Q1 | $1.87M | Buy |
57,714
+877
| +2% | +$27.7K | 0.88% | 39 |
|
|
2016
Q4 | $1.75M | Buy |
56,837
+249
| +0.4% | +$7.6K | 0.92% | 35 |
|
|
2016
Q3 | $1.82M | Buy |
56,588
+4,709
| +9% | +$157K | 1.02% | 33 |
|
|
2016
Q2 | $1.73M | Sell |
51,879
-39,429
| -43% | -$1.26M | 1% | 34 |
|
|
2016
Q1 | $2.57M | Buy |
91,308
+29,020
| +47% | +$829K | 1.46% | 20 |
|
|
2015
Q4 | $1.91M | Sell |
62,288
-49,844
| -44% | -$1.57M | 1.25% | 25 |
|
|
2015
Q3 | $3.34M | Buy |
112,132
+2,514
| +2% | +$80.6K | 2.32% | 7 |
|
|
2015
Q2 | $3.49M | Sell |
109,618
-5,188
| -5% | -$169K | 2.22% | 8 |
|
|
2015
Q1 | $3.23M | Buy |
114,806
+3,038
| +3% | +$96.6K | 2.07% | 9 |
|
|
2014
Q4 | $3.3M | Buy |
111,768
+543
| +0.5% | +$15.6K | 2.15% | 8 |
|
|
2014
Q3 | $3.12M | Sell |
111,225
-3,581
| -3% | -$101K | 2.05% | 11 |
|
|
2014
Q2 | $3.23M | Sell |
114,806
-3,914
| -3% | -$112K | 2.07% | 9 |
|
|
2014
Q1 | $3.62M | Buy |
118,720
+110
| +0.1% | +$3.28K | 2.43% | 8 |
|
|
2013
Q4 | $3.45M | Buy |
118,610
+1,075
| +0.9% | +$31.3K | 2.34% | 6 |
|
|
2013
Q3 | $3.2M | Sell |
117,535
-10,487
| -8% | -$285K | 2.63% | 4 |
|
|
2013
Q2 | $3.37M | Buy |
+128,022
| New | +$3.54M | 3.02% | 4 |
|
Other funds holding PFE
Strategic Advisors's PFE Position: Q2 2026 in Review
Strategic Advisors reduced its Pfizer (PFE) stake by 9.6% in Q2 2026, selling an estimated $50.6K and leaving 18,216 shares worth $439K. The position accounts for 0.1% of the portfolio, ranked #119.
Strategic Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.12M in Q1 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Strategic Advisors held 18,216 shares of Pfizer worth $439K as of Q2 2026.
- Strategic Advisors sold 1,935 Pfizer shares in Q2 2026, an estimated $50.6K.
- Pfizer made up 0.1% of Strategic Advisors's portfolio in Q2 2026, its #119 holding.
- Strategic Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Strategic Advisors's Pfizer position peaked at $8.12M in Q1 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.